Explore ViiV Healthcare

I am a
  • HCP
  • person living with HIV
  • NGO or patient group
  • job seeker
  • member of the public
  • academia / entrepreneur
  • media
...looking for
  • information about VHC medicines
  • clinical data and insights on VHC medicines
  • Independent Medical Education
  • medicines in development
  • how VHC is advancing HIV treatment and care
...looking for
  • information about VHC medicines
  • information and support about living with HIV
  • how to report a side effect
  • news and stories from ViiV Healthcare
...looking for
  • funding / grants
  • ViiV Healthcare's approach to partnerships
  • how ViiV Healthcare works with NGOs
  • news and stories from ViiV Healthcare
  • connect with ViiV Healthcare's community
...looking for
  • job opportunities
  • information about ViiV Healthcare
  • ViiV Healthcare's office locations
  • news and stories from ViiV Healthcare
...looking for
  • who are ViiV Healthcare
  • corporate ethics & compliance
  • news and stories from ViiV Healthcare
...looking for
  • opportunities to partner with ViiV Healthcare
  • information on ViiV Healthcare's Innovation Unit
  • news and stories from ViiV Healthcare
...looking for
  • press releases
  • ViiV Healthcare's Leadership
  • news and stories from ViiV Healthcare

Rukobia

Rukobia (fostemsavir) is listed on the Australian Register of Therapeutic Goods (ARTG).

RUKOBIA is used, in combination with other anti-retroviral agents, to treat Human Immunodeficiency Virus (HIV) infection in adults aged 18 years and over. RUKOBIA contains fostemsavir trometamol, which is changed in the body to the active form of the drug, temsavir. RUKOBIA is a type of medicine known as an anti-retroviral. It belongs to a group of drugs called attachment inhibitors (AIs). It works by binding to the virus and then blocking HIV from attaching to, and infecting, your blood cells.

RUKOBIA doesn’t cure HIV infection; it reduces the amount of virus in your body and keeps it at a low level.

Resources

For patients:

For HCPs:

Date of Preparation: August 2021. PM-AU-HVX-WCNT-210006